Published online Nov 15, 2024. doi: 10.4239/wjd.v15.i11.2245
Revised: September 22, 2024
Accepted: September 25, 2024
Published online: November 15, 2024
Processing time: 89 Days and 4.6 Hours
The rising prevalence of diabetes and prediabetes globally necessitates a deeper understanding of associated complications, including glymphatic system dysfunction. The glymphatic system, crucial for brain waste clearance, is imp-licated in cognitive decline and neurodegenerative diseases like Alzheimer’s disease. This letter explores recent research on glymphatic function across different glucose metabolism states. Tian et al’s study reveals significant glym-phatic dysfunction in type 2 diabetes mellitus patients, evidenced by lower diffusion tensor imaging analysis along perivascular space indices compared to those with normal glucose metabolism and prediabetes. The research also reveals a link between glymphatic dysfunction and cognitive impairment. Additional research underscores the role of glymphatic impairment in neurodegenerative diseases. These findings highlight the importance of integrating glymphatic health into diabetes management and suggest potential biomarkers for early diagnosis and targeted therapeutic interventions.
Core Tip: Integrating glymphatic system health into diabetes management can improve patient outcomes by addressing both cognitive and physiological complications. Recent studies show significant glymphatic dysfunction in type 2 diabetes mellitus patients and its correlation with cognitive decline. Identifying clinical variables influencing glymphatic function may offer biomarkers for early diagnosis and targeted inter-ventions, enhancing the management of diabetes-related cognitive impairments.